| dc.contributor.author | Othieno-Abinya, N. A. | |
| dc.contributor.author | Nyabola, L. O. | |
| dc.contributor.author | Kiarie, Gladwell W | |
| dc.contributor.author | Ndege, R. | |
| dc.contributor.author | Maina, J. M.D. | |
| dc.date.accessioned | 2013-04-17T08:13:11Z | |
| dc.date.issued | 2002-11 | |
| dc.identifier.citation | East Afr Med J. | en |
| dc.identifier.uri | http://www.ajol.info/index.php/eamj/article/view/8805 | |
| dc.identifier.uri | http://hdl.handle.net/11295/16233 | |
| dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/12630493 | |
| dc.description.abstract | OBJECTIVE: To determine the clinical and haematological factors associated with treatment and outcome of chronic myeloid leukaemia (CML) at Kenyatta National Hospital. DESIGN: Retrospective survey of patients treated for chronic myeloid leukaemia. SETTING: Kenyatta National hospital, Nairobi, Kenya, between April 1990 and August 2000. SUBJECTS: Patients with chronic myeloid leukaemia. RESULTS: One hundred and four patients, 55 males and 49 females, age range 10-72 years with a median age of 35 years. Treatment with busulphan getting less popular in favour of hydroxyurea. Median follow-up 20 months with none of the clinical and haematological parameters impacting significantly on duration of follow-up. CONCLUSION: CML occurs at a younger age-group in Kenya, and none of the clinical or haematological parameters appears to impact on follow-up duration. | en |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | Vol. 79(11):593-7; | |
| dc.title | Chronic myeloid leukaemia at the Kenyatta National Hospital, Nairobi | en |
| dc.type | Article | en |
| local.publisher | Department of Medicine. College of Health Sciences. University of Nairobi | en |
